A Tale of Two Chains: Light-Chain Proximal Tubulopathy and Amyloidosis

Introduction: MGRS and AL amyloidosis arise from abnormal monoclonal light chains or misfolded antibody fragments causing kidney disease via paraproteins, without meeting criteria for MM, WM, CLL, or lymphoma. MGRS is diagnosed by monoclonal immunoglobulin deposits on kidney biopsy, subcategorized by ultrastructure and organization. Paraprotein biochemical properties determine lesion type and location. Concurrent lesions are rare due to the clonal nature of these disorders. Case Description: A 74-year-old male with IgG kappa MGUS presented with kidney injury and nephrotic-range proteinuria. Serum creatinine rose from 1.0 to 1.77 mg/dL, albumin was 2.9 g/dL, κ/λ ratio increased from 8.68 to 14.12, M spike rose from 205 to 351 mg. Exam showed +1 edema and ecchymosis. Recommendations of a kidney bopsy revealed congested glomeruli, mesangial thickening, and hyalinization. Proximal tubules had eosinophilic crystalline material, with severe tubular atrophy and fibrosis. Congo red-positive material was in glomeruli and interstitium. Immunofluorescence detected IgG and Κ. Electron microscopy showed fibrils and rod-like crystals, confirming IgG-Κ AL amyloidosis and light chain proximal tubulopathy. Discussion: Mouse studies injected with Bence-Jones proteins from MGRS patients produced matching renal lesions, suggesting paraprotein properties drive lesion diversity. No case series has reported concurrent AL amyloidosis and LCPT. Said et al. reported 63% of 37 patients with AL amyloidosis and light chain deposition disease developed kidney failure, with 56% mortality over 16 months. Pathophysiology of concurrent AL and LCPT may involve light chain conformations or biclonal gammopathy. Clone-directed therapy outperforms immunosuppressive therapy for MGRS-related kidney diseases, preserving kidney function. This case highlights the complex spectrum of protein deposition in monoclonal gammopathies and the need for further research into clonal mechanisms.Proximal tubules showing crystalline structures

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.2025dtwr06x9
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Tale of Two Chains: Light-Chain Proximal Tubulopathy and Amyloidosis

Kazi Khan, Donghyang Kwon, Abraham W. Aron
Journal of the American Society of Nephrology
Amyloidosis: Diagnosis, Treatment, Outcomes
article

A Tale of Two Chains: Light-Chain Proximal Tubulopathy and Amyloidosis

Kazi Khan, Donghyang Kwon, Abraham W. Aron
article en

Abstract

Introduction: MGRS and AL amyloidosis arise from abnormal monoclonal light chains or misfolded antibody fragments causing kidney disease via paraproteins, without meeting criteria for MM, WM, CLL, or lymphoma. MGRS is diagnosed by monoclonal immunoglobulin deposits on kidney biopsy, subcategorized by ultrastructure and organization. Paraprotein biochemical properties determine lesion type and location. Concurrent lesions are rare due to the clonal nature of these disorders. Case Description: A 74-year-old male with IgG kappa MGUS presented with kidney injury and nephrotic-range proteinuria. Serum creatinine rose from 1.0 to 1.77 mg/dL, albumin was 2.9 g/dL, κ/λ ratio increased from 8.68 to 14.12, M spike rose from 205 to 351 mg. Exam showed +1 edema and ecchymosis. Recommendations of a kidney bopsy revealed congested glomeruli, mesangial thickening, and hyalinization. Proximal tubules had eosinophilic crystalline material, with severe tubular atrophy and fibrosis. Congo red-positive material was in glomeruli and interstitium. Immunofluorescence detected IgG and Κ. Electron microscopy showed fibrils and rod-like crystals, confirming IgG-Κ AL amyloidosis and light chain proximal tubulopathy. Discussion: Mouse studies injected with Bence-Jones proteins from MGRS patients produced matching renal lesions, suggesting paraprotein properties drive lesion diversity. No case series has reported concurrent AL amyloidosis and LCPT. Said et al. reported 63% of 37 patients with AL amyloidosis and light chain deposition disease developed kidney failure, with 56% mortality over 16 months. Pathophysiology of concurrent AL and LCPT may involve light chain conformations or biclonal gammopathy. Clone-directed therapy outperforms immunosuppressive therapy for MGRS-related kidney diseases, preserving kidney function. This case highlights the complex spectrum of protein deposition in monoclonal gammopathies and the need for further research into clonal mechanisms.Proximal tubules showing crystalline structures

Journal of the American Society of NephrologyVol. 36(10S)
Georgetown University (US), MedStar Georgetown University Hospital (US)
Openalex Percentile: Top 66%
Amyloidosis: Diagnosis, Treatment, Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.